TLR5 and colitis: Administration of EcNΔfliC to DSS-treated Tlr5−/− mice did not positively affect the outcome of experimental colitis, as demonstrated by HCSs comparable to EcNΔfliC-treated WT mice and to DSS-only–treated mice of both genotypes (Fig 1E; see also S1 Table for detailed statistical analysis).